1. Cabozantinib and Vandetanib in medullary thyroid carcinoma: mitochondrial function and its potential as a therapeutic target towards novel strategies to design anti-CSCs drugs. Issue 10 (3rd October 2018) Authors: Tampaki, Ekaterini Christina; Tampakis, Athanasios; Droeser, Raoul; Patsouris, Efstratios; Kouraklis, Gregory Journal: Cancer biology & therapy Issue: Volume 19:Issue 10(2018) Page Start: 847 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Letter by Tampaki et al Regarding Article, "Cardiovascular Effects of New Oral Glucose-Lowering Agents: DPP-4 and SGLT-2 Inhibitors". Issue 4 (3rd August 2018) Authors: Tampaki, Ekaterini Christina; Tampakis, Athanasios; Gürke, Lorenz; Pantos, Costas Journal: Circulation research Issue: Volume 123:Issue 4(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Letter by Tampaki et al Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)". Issue 9 (27th February 2018) Authors: Tampaki, Ekaterini Christina; Tampakis, Athanasios; Pantos, Costas Journal: Circulation Issue: Volume 137:Issue 9(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Letter by Tampakis et al Regarding Article, "Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease". Issue 8 (21st August 2018) Authors: Tampakis, Athanasios; Tampaki, Ekaterini Christina; Gürke, Lorenz Journal: Circulation Issue: Volume 138:Issue 8(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗